Viking Holdings Ltd. VIK 深 沪
已收盘 08-01 16:00:00 美东时间
57.56
-1.160
-1.98%
华盛通- 最 高57.89
- 今 开57.42
- 成交量 263.13万股
- 最 低 56.1508
- 昨 收 58.72
- 总市值 254.99亿
- 52周最高 59.97
- 市盈率 静 163.11
- 换手率 0.59%
- 52周最低 30.75
- 委 比 98.60%
- 总股本 4.43亿
- 历史最高 59.97
- 量 比 1.01
- 振 幅 2.96%
- 历史最低 25.71
- 每 手 1
- 风险率 2.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Celcuity Announces Positive Phase 3 Trial Results
Celcuity ( ($CELC) ) has shared an announcement. On July 28, 2025, Celcuity Inc...
07-28 19:55
Market-Moving News for July 28th
CELC: 133% | Celcuity Released Topline Results From PIK3CA Wild-Type Cohort Of Phase 3 VIKTORIA-1 Trial Of Gedatolisib Plus Fulvestrant With And Without Palbociclib Versus Fulvestrant In Advanced Breast
07-28 19:36
Celcuity shares are trading higher after the company announced it will disclosed the topline results of the PIK3CA Wild-Type Cohort from the Phase 3 VIKTORIA-1 trial.
Celcuity shares are trading higher after the company announced it will disclose...
07-26 04:10
Avila Energy Corporation Revokes Cease Trade Order, Plans to Resume Trading
Petro Viking Energy ( ($TSE:VIK) ) has issued an update. Avila Energy Corporati...
07-22 01:09
Citigroup Maintains Buy on Viking Holdings, Raises Price Target to $68
Citigroup analyst James Hardiman maintains Viking Holdings (NYSE:VIK) with a Buy and raises the price target from $57 to $68.
07-16 23:05
美股大行评级 | 潜在涨幅107.37%！花旗上调ProKidney目标价至9美元，维持"买入"评级
今日重点评级关注：花旗：维持ProKidney Corp. - Class A Ordinary Shares"买入"评级，目标价从6美元升至9美元；Canaccord Genuity：维持e.l.f. Beauty"买入"评级，目标价从114美元升至150美元
07-10 09:55
Shares of travel-linked stocks are trading higher following strong earnings from Delta Air Lines.
Shares of travel-linked stocks are trading higher following strong earnings fro...
07-11 02:27
Delta Air Lines' upbeat outlook fuels travel rally
Travel-related stocks are getting a lift on Thursday thanks to Delta Air Lines’ (NYSE:DAL) bullish quarterly results and the carrier’s upbeat outlook on travel trends. Delta (NYSE:DAL) shares rallied ...
07-11 01:40
美股大行评级 | 潜在涨幅199.47%！杰富瑞上调Cogent Biosciences目标价至28美元，维持"买入"评级
今日重点评级关注：杰富瑞：维持Cogent Biosciences"买入"评级，目标价从23美元升至28美元；Leerink Partners：维持Cogent Biosciences"跑赢大市"评级，目标价从16美元升至18美元
07-08 09:34
Jefferies Maintains Hold on Viking Holdings, Raises Price Target to $52
Jefferies analyst David Katz maintains Viking Holdings (NYSE:VIK) with a Hold and raises the price target from $45 to $52.
07-08 00:25
